Non-neurogenic Chronic Urinary Retention: What Are We Treating?
- 436 Downloads
Purpose of Review
This review examines current terminology used to define non-neurogenic chronic urinary retention (CUR), describes the pathophysiology of urinary retention, and highlights contemporary diagnostic and treatment algorithms.
There is no standardized definition for the condition, but volumes >300 ml are commonly used to describe CUR. It is a clinical diagnosis which does not require urodynamics. Pathophysiologic causes of CUR be from myogenic, neurogenic, bladder outlet obstruction, or a combination of these sources. Treatment algorithms recommend stratifying patients with chronic urinary retention by risk and by symptoms before initiating treatment. Common CUR outcome endpoints need to be better utilized so that treatment modalities can be compared.
Non-neurogenic CUR is a heterogeneous condition that has multiple definitions, underlying physiologies, and possible endpoints. Standardization is needed to better understand and treat CUR.
KeywordsUrinary retention Bladder outlet obstruction Underactive bladder
Compliance with Ethical Standards
Conflict of Interest
John Stoffel reports grants from PCORI and Uroplasty.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 4.•• Stoffel JT, Peterson AC, Sandhu JS, Suskind AM, Wei JT, Lightner DJ. AUA white paper: non-neurogenic chronic urinary retention: consensus definition, treatment algorithm, and outcome endpoints. J Urol 2017. AUA Quality Improvement and Patient Safety committee sponsored this white paper to create a standardized CUR definition, treatment algorithm, and treatment endpoints based on available evidence.Google Scholar
- 13.Cohn JA, Ni S, Kaufman MR, Graves AJ, Penson DF, Dmochowski RR, et al. Urinary retention and catheter use among U.S. female Medicare beneficiaries: prevalence and risk factors. Neurourol Urodyn 2017.Google Scholar
- 16.Mansfield KJ, Liu L, Mitchelson FJ, Moore KH, Millard RJ, Burcher E. Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing. Br J Pharmacol. 2005;144(8):1089–99.CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Burmeister D, Abou Shwareb T, D'Agostino R Jr, Andersson KE, Christ GJ. Impact of partial urethral obstruction on bladder function: time-dependent changes and functional correlates of altered expression of Ca(2)(+) signaling regulators. Am J Physiol Renal Physiol. 2012;302(12):F1517–28.CrossRefPubMedPubMedCentralGoogle Scholar
- 40.• Kalejaiye O, Speakman MJ. Management of acute and chronic retention in men. Eur Urol. 2009;8(6):523–529. National Health System algorithm for treating CUR Google Scholar
- 41.•• Brasure M, Fink HA, Risk M, Mac Donald R, Shamliyan T, Ouellette J, et al. Chronic urinary retention: comparative effectiveness and harms of treatments. Rockville (MD): AHRQ Comparative Effectiveness Reviews; 2014. AHRQ literature review comparing effectiveness of CUR treatments. The heterogeneity in endpoints identified in this report lead to genesis of AUA publishing white paper on the subject Google Scholar
- 42.Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549–57. discussion 64CrossRefPubMedGoogle Scholar
- 43.Averch TD SJ, Goldman HB, Griebling TL, Lerner L, Newman DK, Peterson AC. AUA white paper on catheter associated urinary tract infections: definitions and significance in the urological patient. Urology Practice. 2015; 2(6).Google Scholar
- 45.•• Smith PP, Birder LA, Abrams P, Wein AJ, Chapple CR. Detrusor underactivity and the underactive bladder: symptoms, function, cause-what do we mean? ICI-RS think tank 2014. Neurourol Urodyn. 2016;35(2):312–7. Expert opinion conference on how to define and study underactive bladder CrossRefPubMedGoogle Scholar